Discovery Communicatns New (DISCA) Share Value Declined While Yakira Capital Management Has Trimmed by $876,918 Its Position; Pentwater Capital Management LP Holds Holding in Esperion Therapeutics (ESPR)

February 15, 2018 - By Maria Brooks

Matthew Halbower increased its stake in Esperion Therapeutics Inc (ESPR) by 12.84% based on its latest 2017Q3 regulatory filing with the SEC. Pentwater Capital Management Lp bought 255,200 shares as the company’s stock rose 33.24% with the market. The hedge fund run by Matthew Halbower held 2.24 million shares of the health care company at the end of 2017Q3, valued at $112.43 million, up from 1.99M at the end of the previous reported quarter. Pentwater Capital Management Lp who had been investing in Esperion Therapeutics Inc for a number of months, seems to be bullish on the $1.93B market cap company. The stock increased 5.39% or $3.77 during the last trading session, reaching $73.76. About 636,735 shares traded or 8.31% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since February 15, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

Yakira Capital Management Inc decreased its stake in Discovery Communicatns New (DISCA) by 46.35% based on its latest 2017Q3 regulatory filing with the SEC. Yakira Capital Management Inc sold 41,758 shares as the company’s stock declined 9.80% while stock markets rallied. The hedge fund held 48,333 shares of the consumer services company at the end of 2017Q3, valued at $1.03M, down from 90,091 at the end of the previous reported quarter. Yakira Capital Management Inc who had been investing in Discovery Communicatns New for a number of months, seems to be less bullish one the $14.88B market cap company. The stock increased 1.27% or $0.3 during the last trading session, reaching $23.83. About 4.36 million shares traded. Discovery Communications, Inc. (NASDAQ:DISCA) has declined 0.88% since February 15, 2017 and is downtrending. It has underperformed by 17.58% the S&P500.

Investors sentiment increased to 1.67 in 2017 Q3. Its up 0.45, from 1.22 in 2017Q2. It is positive, as 11 investors sold ESPR shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. Pinnacle Associate Limited holds 717,813 shares. Gilder Gagnon Howe Ltd invested in 0% or 1,689 shares. Partner Fund Mgmt LP invested 0.54% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). New York-based Bnp Paribas Arbitrage Sa has invested 0.02% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Jane Street Group Lc holds 0% or 11,247 shares. 880,323 were reported by Vanguard Gp Incorporated. 577,917 were accumulated by Northern Tru. 3,423 are held by Sg Americas Ltd Llc. Millennium Mngmt Limited Liability Com has invested 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Nationwide Fund Advisors invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Rhenman And Prns Asset Mngmt, Sweden-based fund reported 311,803 shares. Pictet Asset Mgmt has invested 0.04% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Fmr Ltd Co owns 1.34M shares. Geode Management Ltd Liability Corp has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Jpmorgan Chase Com has 61,800 shares.

Pentwater Capital Management Lp, which manages about $5.28 billion and $11.65B US Long portfolio, decreased its stake in Turquoise Hill Res Ltd (NYSE:TRQ) by 2.88M shares to 96.29M shares, valued at $298.49 million in 2017Q3, according to the filing. It also reduced its holding in Silverbow Res Inc by 36,081 shares in the quarter, leaving it with 541,668 shares, and cut its stake in Synchrony Finl (Put).

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Esperion Therapeutics had 53 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Sell” rating by Chardan Capital Markets on Monday, August 31. The firm has “Underperform” rating given on Wednesday, June 29 by Credit Suisse. As per Monday, August 10, the company rating was upgraded by Needham. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Strong Buy” rating given on Wednesday, August 19 by Needham. As per Wednesday, February 24, the company rating was maintained by Barclays Capital. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Outperform” rating given on Friday, November 6 by RBC Capital Markets. Chardan Capital Markets maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Monday, July 27 with “Sell” rating. The stock has “Neutral” rating by JP Morgan on Wednesday, June 29. The firm has “Buy” rating by Stifel Nicolaus given on Monday, June 26. Lake Street maintained it with “Buy” rating and $27 target in Wednesday, June 29 report.

Investors sentiment increased to 0.92 in 2017 Q3. Its up 0.10, from 0.82 in 2017Q2. It increased, as 65 investors sold DISCA shares while 163 reduced holdings. 57 funds opened positions while 152 raised stakes. 204.44 million shares or 4.84% more from 195.01 million shares in 2017Q2 were reported. The New York-based Rafferty Asset Mgmt Ltd Liability has invested 0.02% in Discovery Communications, Inc. (NASDAQ:DISCA). Private Mgmt Grp Inc holds 1.38M shares. Robeco Institutional Asset Mngmt Bv reported 0% in Discovery Communications, Inc. (NASDAQ:DISCA). Mackenzie Financial accumulated 1.34M shares or 0.15% of the stock. Hsbc Public Ltd Company holds 127,552 shares. New South Cap Mngmt Incorporated reported 4.66 million shares or 2.37% of all its holdings. The Minnesota-based Walleye Trading Lc has invested 0% in Discovery Communications, Inc. (NASDAQ:DISCA). Blackrock owns 13.42 million shares. Everence Mngmt stated it has 13,725 shares. Bnp Paribas Arbitrage holds 128,782 shares or 0.01% of its portfolio. First National Bank & Trust Of Omaha has 0.09% invested in Discovery Communications, Inc. (NASDAQ:DISCA) for 53,062 shares. Cibc Ww Mkts reported 0% in Discovery Communications, Inc. (NASDAQ:DISCA). The United Kingdom-based Aviva Public Limited Co has invested 0.01% in Discovery Communications, Inc. (NASDAQ:DISCA). Macquarie Gru Limited has 0% invested in Discovery Communications, Inc. (NASDAQ:DISCA) for 27,300 shares. Advantus Cap reported 20,562 shares.

Since December 13, 2017, it had 3 insider buys, and 1 sale for $10.39 million activity. $2.03 million worth of Discovery Communications, Inc. (NASDAQ:DISCA) shares were bought by MALONE JOHN C. Campbell Bruce also sold $55,349 worth of Discovery Communications, Inc. (NASDAQ:DISCA) on Wednesday, December 13.

Yakira Capital Management Inc, which manages about $188.00 million and $300.65 million US Long portfolio, upped its stake in Bard C R Inc (NYSE:BCR) by 3,350 shares to 68,350 shares, valued at $21.91M in 2017Q3, according to the filing. It also increased its holding in Digitalglobe Inc (NYSE:DGI) by 35,741 shares in the quarter, for a total of 130,725 shares, and has risen its stake in Viacom Inc New (NASDAQ:VIAB).

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>